Tianjin TEDA Biomedical Engineering Company Limited reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 476.38 million compared to CNY 369.36 million a year ago. Net loss was CNY 42.26 million compared to CNY 48 million a year ago.

Basic loss per share from continuing operations was CNY 0.0223 compared to CNY 0.0253 a year ago.